Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Patrick Connor Johnson"'
Autor:
Hazim S. Ababneh, Andrea K. Ng, Matthew J. Frigault, Jeremy S Abramson, Patrick Connor Johnson, Caron A. Jacobson, Chirayu G. Patel
Publikováno v:
Haematologica, Vol 108, Iss 11 (2023)
Despite the success of CD19-targeted chimeric antigen receptor (CAR T)-cell therapy in patients with relapsed/refractory large B-cell lymphoma (LBCL), there is a need for effective salvage strategies post-CAR T-cell therapy failure. We conducted a mu
Externí odkaz:
https://doaj.org/article/4a2ced42a6da469fb8f751f77f667624
Autor:
Kevin Charles Miller, Patrick Connor Johnson, Jeremy S. Abramson, Jacob D. Soumerai, Andrew J. Yee, Andrew R. Branagan, Elizabeth K. O’Donnell, Anna Saucier, Caron A. Jacobson, Matthew J. Frigault, Noopur S. Raje
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 10, Pp 1-12 (2022)
Abstract Chimeric antigen receptor T cells (CAR T) are groundbreaking therapies but may cause significant toxicities including cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), and cytopenias. Granulocyt
Externí odkaz:
https://doaj.org/article/3228817cf75c47368f94792a61f6aa4d
Autor:
Bimarzhan Assatova, Christopher Trevisani, Robert Willim, Jessica Duffy, Abner Louissaint, Won-Seog Kim, David J Feith, Thomas Loughran, Foster Powers, Elizabeth A Morgan, Lei Yang, Brandy Pinckney, Garrett Haskett, Matthew J Cotton, Andrew Crabbe, Jessica Beth Ziemba, Ian Brain, Tayla B. Heavican-Foral, Nora Scanlan, Gail Newton, Jaehyuk Choi, Jeffrey A Barnes, Patrick Connor Johnson, Eric D Jacobsen, Steven Greenberg, David M. Weinstock, Salvia Jain
Publikováno v:
Blood. 140:2253-2255
Autor:
Richard Andrew Newcomb, Patrick Connor Johnson, Hermioni Lokko Amonoo, Nikka Yamin, Maanasi Gothoskar, Joanna Choe, Dr. Yi-Bin Chen, Zachariah DeFilipp, Areej R. El-Jawahri
Publikováno v:
Transplantation and Cellular Therapy. 29:S360-S361
Autor:
Uvette Lou, Matthew M Lei, Mark Sorial, Daniel Lage, Kenechukwu Aniagboso, Emily Buttermore, Margaret Soriano, Ryan D. Nipp, Patrick Connor Johnson
Publikováno v:
Blood. 140:13088-13089
Autor:
Patrick Connor Johnson, Tejaswini Dhawale, Mitchell W. Lavoie, Kyle Karpinski, Netana H. Markovitz, Kathleen Hennessey, Matthew Frigault, Areej El-Jawahri
Publikováno v:
Blood. 140:5232-5233
Autor:
Hermioni Lokko Amonoo, Netana H. Markovitz, Patrick Connor Johnson, Ciara Dale, Emma C. Deary, Elizabeth Daskalakis, Joanna Choe, Nikka Yamin, Maanasi Gothoskar, Anne Kwok, Carlos Fernandez-Robles, William Pirl, Dr. Yi-Bin Chen, Dr. Corey Cutler, Charlotta Lindvall, Areej R. El-Jawahri
Publikováno v:
Transplantation and Cellular Therapy. 29:S152
Autor:
Mehdi Hamadani, Xianmiao Qiu, Peiman Hematti, Lazaros J. Lekakis, Dipenkumar Modi, Megan M. Herr, Premal Lulla, Vijaya Raj Bhatt, Soyoung Kim, Aleksandr Lazaryan, Patrick Connor Johnson, Vaibhav Agrawal, Hamza Hashmi, Natalie S Grover, Marcelo C. Pasquini, Andrew Daly, Frederick L. Locke, Ajay K. Gopal, Sairah Ahmed, Stefan O. Ciurea, Jordan Gauthier, P.B. Dahi
Publikováno v:
Blood advances, vol 6, iss 2
Blood Advances
Blood Advances
Key Points CIBMTR prognostic score predicts PFS and OS of patients with DLBCL receiving axicabtagene ciloleucel treatment after a prior autoHCT failure.CIBMTR high/very high-risk score marks an adverse risk cohort where novel immunotherapy or relapse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54e18b73535c8228182870e83f450144
https://escholarship.org/uc/item/8909h989
https://escholarship.org/uc/item/8909h989
Autor:
Netana H. Markovitz, Areej El-Jawahri, Ciara Dale, Patrick Connor Johnson, Kofi Boateng, Daniel Yang, Hermioni L. Amonoo
Publikováno v:
Blood. 140:8137-8137
Autor:
Daniel E Lage, Patrick Connor Johnson, Shira Hornstein, Isabel Neckermann, Alane Schmelkin, Connor Grayzel, Patricia Brown, Meghan McGrath, Eliza Shulman, Melissa Smith, Ryan David Nipp, Areej El-Jawahri
Publikováno v:
Journal of Clinical Oncology. 40:295-295
295 Background: Patients with advanced cancer often experience frequent and prolonged hospitalizations, and the transition from hospital to home represents a critical period for these individuals, as they prefer to maximize time at home and avoid rea